Cargando…

Tyrosine Sulfation: A New Player and Potential Target in Pancreatic Cancer

Detalles Bibliográficos
Autores principales:	Zhang, Yaqing, Pasca di Magliano, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444954/ https://www.ncbi.nlm.nih.gov/pubmed/37423257 http://dx.doi.org/10.1016/j.jcmgh.2023.06.007

Ejemplares similares

Therapeutic Potential of Targeting Stromal Crosstalk-Mediated Immune Suppression in Pancreatic Cancer
por: Du, Wenting, et al.
Publicado: (2021)

Immune cells in pancreatic cancer: Joining the dark side
por: Zhang, Yaqing, et al.
Publicado: (2014)

Kras as a key oncogene and therapeutic target in pancreatic cancer
por: Collins, Meredith A., et al.
Publicado: (2014)

Epithelial Notch signaling is a limiting step for pancreatic carcinogenesis
por: Thomas, Marsha M, et al.
Publicado: (2014)

Early pancreatic islet fate and maturation is controlled through RBP-Jκ
por: Cras-Méneur, Corentin, et al.
Publicado: (2016)

Myeloid Cell Mediated Ilmmune Suppression in Pancreatic Cancer
por: Kemp, Samantha B., et al.
Publicado: (2021)

Metastatic Pancreatic Cancer Is Dependent on Oncogenic Kras in Mice
por: Collins, Meredith A., et al.
Publicado: (2012)

Pancreatic Fibroblast Heterogeneity: From Development to Cancer
por: Garcia, Paloma E., et al.
Publicado: (2020)

Fbxw7 Deletion Accelerates Kras(G12D)-Driven Pancreatic Tumorigenesis via Yap Accumulation()()()
por: Zhang, Qiang, et al.
Publicado: (2016)

Epithelial-Myeloid cell crosstalk regulates acinar cell plasticity and pancreatic remodeling in mice
por: Zhang, Yaqing, et al.
Publicado: (2017)

Mitogen-activated Protein Kinase Kinase Activity Maintains Acinar-to-Ductal Metaplasia and Is Required for Organ Regeneration in Pancreatitis
por: Halbrook, Christopher J., et al.
Publicado: (2016)

Differential Contribution of Pancreatic Fibroblast Subsets to the Pancreatic Cancer Stroma
por: Garcia, Paloma E., et al.
Publicado: (2020)

Utilizing past and present mouse systems to engineer more relevant pancreatic cancer models
por: DeCant, Brian T., et al.
Publicado: (2014)

Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer
por: Zhang, Yaqing, et al.
Publicado: (2017)

Cleaved CDCP1 marks the spot: a neoepitope for RAS-driven cancers
por: Donahue, Katelyn L., et al.
Publicado: (2022)

WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancer
por: Du, Wenting, et al.
Publicado: (2022)

New tools for evaluating protein tyrosine sulfation and carbohydrate sulfation
por: Yeoh, Sharon, et al.
Publicado: (2018)

Back to the drawing board: Re-thinking the role of GLI1 in pancreatic carcinogenesis
por: Hogenson, Tara L., et al.
Publicado: (2016)

Change isn't always better
por: Schofield, Heather, et al.
Publicado: (2015)

Tyrosine Sulfation of Statherin
por: Kasinathan, C., et al.
Publicado: (2007)

Notch signaling regulates immunosuppressive tumor-associated macrophage function in pancreatic cancer
por: Yan, Wei, et al.
Publicado: (2023)

The Gustatory Sensory G-Protein GNAT3 Suppresses Pancreatic Cancer Progression in Mice
por: Hoffman, Megan T., et al.
Publicado: (2020)

Metabolism and Cancer: Old and New Players
por: Cerella, Claudia, et al.
Publicado: (2013)

Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth()
por: Pal, Anupama, et al.
Publicado: (2017)

Hypoxia promotes an inflammatory phenotype of fibroblasts in pancreatic cancer
por: Mello, Ashley M., et al.
Publicado: (2022)

New Drugs and Novel Cellular Targets against Tuberculosis
por: Degiacomi, Giulia, et al.
Publicado: (2022)

Multiomic characterization of pancreatic cancer-associated macrophage polarization reveals deregulated metabolic programs driven by the GM-CSF–PI3K pathway
por: Boyer, Seth, et al.
Publicado: (2022)

Targeting Tyrosine Kinases in Cancer: Lessons for an Effective Targeted Therapy in the Clinic
por: Angelucci, Adriano
Publicado: (2019)

Beta 1 integrin signaling mediates pancreatic ductal adenocarcinoma resistance to MEK inhibition
por: Brannon, Arthur, et al.
Publicado: (2020)

3373 Modulation of Hedgehog Signaling Alters Immune Infiltration in Pancreatic Cancer
por: Steele, Nina, et al.
Publicado: (2019)

Targeting Protein-Tyrosine Phosphatases in Breast Cancer
por: Aceto, Nicola, et al.
Publicado: (2012)

Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target
por: Gillson, Josef, et al.
Publicado: (2022)

ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis
por: Wang, Lidong, et al.
Publicado: (2015)

Arginase 1 is a key driver of immune suppression in pancreatic cancer
por: Menjivar, Rosa E, et al.
Publicado: (2023)

Tyrosine Kinases in Cancer
por: Blau, Olga, et al.
Publicado: (2015)

Cdc14b: A New Player in Aging
por: Wei, Zhubo, et al.
Publicado: (2011)

Circular RNA YAP1: a new player in gastric cancer
por: Verduci, Lorena, et al.
Publicado: (2019)

Tacrolimus for prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: a potential new target of old drug?
por: Jeong, Seok
Publicado: (2022)

Cobll1: A new player in CML
por: Kim, Hongtae, et al.
Publicado: (2017)

Editorial: Heparan Sulfate Proteoglycans and Their Endogenous Modifying Enzymes: Cancer Players, Biomarkers and Therapeutic Targets
por: Lanzi, Cinzia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hhj5gu703654cnvn70fttcaou6